This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.
spk02: Greetings and welcome to the Agri-Fi third quarter 2022 earnings conference call. At this time, all participants are in a listen-only mode. A brief question and answer session will follow the formal presentation. If anyone should require operator assistance during the conference, please press star then zero on your telephone keypad. As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Anna Kate Hiller. Please go ahead.
spk01: Good morning and welcome to Agrify's third quarter 2022 earnings call. With us on today's call are Raymond Cheng, Chief Executive Officer, and Timothy Oates, Chief Financial Officer. Today, management will review the highlights and financial results for the third quarter and provide a business and operational update. Following management's remarks, there will be a question and answer session. A reminder that today's conference call is being recorded and a replay will be available on Agrify's investor relations website at ir.agrify.com. Please note that we will be referring to information that's contained within our earnings press release, which can be accessed on the investor relations website as well. Before we begin, we would like to remind everyone that management's remarks contain forward-looking statements, and management may make additional forward-looking statements in response to your questions. Such statements involve a number of known and unknown risks and uncertainties, many of which are outside the company's control that could cause its future results, performance, or achievements to differ significantly from the results, performance, or achievements expressed or implied by such forward-looking statements. Important factors that could cause or contribute to such differences include the risks detailed in our public filings with the Securities and Exchange Commission and those mentioned in the earnings release. Except as required by law, we undertake no obligation to update any forward-looking or other statements therein, whether a result of new information, future events, or otherwise. I will now turn it over to Raymond.
spk07: Thanks, Anna-Kate, and thank you, everyone, for joining us on the call today. I'm going to begin by providing an overview of our performance in Q3, as well as some recent updates on our business. And then our Chief Financial Officer, Tim Oakes, is going to discuss our Q3 financial results in greater detail. After that, I will go over our outlook for the remainder of 2022, and then we will open up the call for questions. For the third quarter, we ended up with $7 million in revenue. It is very important that I explain the shortfall in our Q3 revenue in more detail. As we have disclosed publicly, our customer, Button Marys, defaulted on its construction loan facility, and we served them with a default notice on September 15th. In response, Button Marys filed a baseless lawsuit in attempt to avoid having to repay the credit facility. The lawsuit is entirely without merit and we are taking all necessary steps to pursue repayment from Button Mary's. As a result of the pending lawsuits and based on the ASC 606 Revenue Recognition Standard, we elected not to recognize $5.3 million of design and built revenue related to Button Mary's project in Q3. I want to reiterate that we are confident that we have the legal rights and means necessary to recover the deferred revenue once the legal process runs its course. Button Mary's construction loan is guaranteed by Button Mary's Holding and David Morgan, founder and CEO of Button Mary's personally. You can be assured that Agrify will continue to take every step necessary to pursue repayment from Button Mary's and protect all our shareholders' interests. On top line, Q3 revenue number was also adversely impacted as a result of the tight quarterly cash spending limits imposed by our institutional lender. In order to stay in full compliance, we were forced to make some difficult decisions, but necessary, to end up inhibiting our ability to maximize revenue in Q3. Ideally, we would have liked to convert more of our backlog into revenue. In total, we estimate that the cash spending limit prevented us from realizing approximately $1.8 million in revenue that was otherwise within reach for Q3. In total, we estimate that there was about $7.1 million of the negative impact to our Q3 top line stemming from these two factors. Again, $5.3 million defer due to the Marylis-Button-Marys lawsuits and approximately $1.8 million of business push out to Q4 due to our cash spending limit. Additionally, some of our customers also encounter some unforeseen construction and permitting delays not related to Agrify, which impacted their ability in Q3 to accept some of the products and solutions that they committed to purchase. through Agri-Fight. This had a tangible impact on our Q3 result as well, to the tune of approximately $1.3 million, but these orders are all expected to be shipped in Q4. Despite these hindrances, we generated over $11.2 million in new booking during the third quarter. It is worth noting that starting from Q3, we have decided not to include the expected recurring revenue streams, such as SaaS or production success fee, that often spend multiple years, but do not commence until our customer facilities are fully permitted and operational. Moving forward, we will only associate bookings with hardware sales that we expect to sell in the near term. For SaaS and production success revenues, we will provide the approximate number of VFUs currently under contract and the duration of each recurring revenue. By doing so, I believe this will give everyone a clearer picture of our near-term revenue potential as well as our more exciting long-term recurring revenue streams. Again, the booking for Q3 without the SAS and production success fee was approximately $11.2 million as these are all hardware sales that we could realize in the near term. The additional bookings on SaaS and production fees ranges between five to 10 years with some production revenues attached to it. As the broader business environment continues to be a very challenging one to navigate, we have remained nimble by continuing to adjust our operating approach adapt to evolving customer needs, and develop and deploy technology that is versatile and scalable. We also continue to make progress with our growing product portfolio and are seeing very strong traction with our recent innovations and product offerings. With regard to our operating approach, we have talked in the past about cost reduction and cost efficiency measures we have instituted to promote cash conservation during the industry downturn. To ensure the health of our business, we continue to pursue cost-saving initiatives that will better position our business over the long term to capitalize when the industry returns to growth. I want to be clear that many of the cost reduction and cost efficiency initiatives we discussed last quarter have already been implemented and are still in effect and we are actively evaluating other possibilities as well as we look to protect the company from the turbulence we have encountered in recent months. Now, some of the other developments. We continue to see very strong traction with our rapid deployment program, the RDPs. We recently announced three new RDP customers in Illinois, Massachusetts, and South Africa. The combined agreements for these three new customers have an expected base value of $7.5 million in cultivation-related hardware sales. On top, there are also future recurring SAS and production success fees. As a reminder, the RDP program was designed to lower the barrier to entry and upfront investment needed for customers to access the best-in-class pluck-and-play cultivation and extraction capability with an accelerated path to profitability. Using the RDP programs, each customer will have the potential to produce an estimated 7.5 pounds of premium-quality flowers per VFU per growth cycle, with approximately 5.2 growth cycles expected to be possible each year. We are excited to see early customer success with the RDPs. and look forward to bringing the RDP program to even more customers throughout the world. We intend to start taking orders for a greater volume of RDPs starting in the first quarter of 2023 and also in the upcoming MJBiz. We also look forward to showcasing our latest development and advancement in the RDP programs at MJBiz next week. and we will have more to share on that front in the coming days. On the extraction side, I am pleased that we recently announced successful commercialization of the PX10 hydrocarbon cannabis extractor that was initially unveiled in August. The PX10 will soon be installed at three customer facilities, including at a key customer site in Maryland belonging to Alchemist Ventures. Our progress with the PX10 has demonstrated our ability to not only successfully turn a product vision into reality, but also our capacity to work closely with a growing number of prominent customers, including multi-state operators to enable them to our cutting edge solution to grow their business. I'm also happy to report that the development of our new 3.7 VFUs is now complete. and we expect to start shipping these units to customers in the first quarter of 2023. Regarding our TTK projects, the Button Mary project is obviously on hold. The other three customer sites, Treehouse in Nevada, Greenstone in Colorado, and Hannah in Washington, are all left with some mining construction and permitting tasks. We expect that the initial phase of each of these projects will be completed in Q4, at which time the customers are expected to begin to bring in plant materials into their facilities. Once the final license and certification of occupancy are received, which we expect to occur in quarter one, we will be able to start generating the high margin recurring SAS and production revenue shortly thereafter. We still believe that the TTK engagement with our customers across these three facilities will serve as an excellent proof of concept for the underlying business model and the attractive returns of our TTK programs. Last but not least, it was truly an honor for Agrify to be recognized in September when we received the best cultivation technology during the Green Market Report's Tech Summit. The Green Market Report is one of the permanent sources of financial, business, and economic news in the cannabis industry, and its awards recognize companies in the cannabis industry for the creation of innovative products and services. We are a clear leader in the indoor cultivation space, and we have created Agri-Fi has set a new standard for what is possible. In summary, we remain determined to be highly successful over the long term, despite the short-term challenges that we are encountering in recent months. We have conviction in the underlying health of our business for the following reasons. Number one, interest and enthusiasm in our highly differentiated portfolio of cultivation extraction solutions remain strong. As our pipeline of qualified sales opportunities currently stands, and over $31.1 million for cultivation and over $45.9 million for extraction. Our diversified mix of products and services gives us tremendous flexibility to adjust our approach to capitalize on whatever market opportunities are most attractive at any point in time and respond swiftly to challenges that arise in this dynamic operating environment. and probably the most exciting, our products have strong global appeal. And given the quality control is absolutely imperative, especially in the EUs, because of the incredibly high EU GMP standards, we are very confident that our offering will become highly adopted throughout the European market, which is eventually expected to become one of the world's largest market for legal cannabis. Overall, we're getting substantial interest in our cultivation extraction solution from a wide variety of international customers. At this point, I would like to turn the call over to Tim to talk about the financial results for the quarter.
spk05: Thank you, Raymond. Good morning, everyone, and thank you for once again joining us on today's earnings call. As we've done in prior quarters, I'll take some time to speak to our third quarter 2022 financial results, and then I'll pass the call back to Raymond for closing remarks. Like last quarter, there's a lot to digest with respect to our third quarter financial performance. So it is gonna take some time or some extra time to go through everything. Starting with revenue, revenue in the third quarter of 2022 totaled 7 million compared to revenue of 15.8 million in the third quarter of 2021. This represents an 8.8 million or 55.4% year over year decrease in comparative quarterly revenue. The decrease in third quarter 2022 revenue is solely related to a comparative year-over-year decline in our lower-margin design and build revenue. Design and build revenue declined by $11.7 million in the comparative quarterly periods, from $13 million in the third quarter of 2021 to $1.3 million in the third quarter of 2022. It is important to note that third quarter 2022 design and build revenue excludes approximately $5.3 million of revenue associated with our TTK solution projects with Bud and Mary's. This revenue has been deferred as a direct result of Bud and Mary's lawsuit, which challenges our ability to recognize the revenue on the work performed during the quarter as collectability of the amounts becomes uncertain. And as Raymond mentioned in his script earlier, despite the accounting position taken by the company during the current quarter, the company intends to vigorously defend itself against the claims made by Bud and Mary's in its lawsuits and believes that it has the documented support to prevail on this matter and the legal recourse necessary to recover the outstanding amounts due to the company and its stockholders in this matter. The company recognized approximately $5.7 million in extraction-related revenue during the third quarter. No extraction-related revenue was recorded by the company in the third quarter of 2021, as the company had not entered that vertical yet. It is worthwhile to note that the amount of extraction revenue during the third quarter was negatively impacted as a result of the company's debt modification agreement, under which the company was unable to ship approximately $1.8 million of extraction equipment due to the quarterly cash spend limits imposed under the restructured debt agreement. Bookings for the third quarter of 2022 were approximately $11.2 million, of which $5.6 million was related to extraction products. We enter the fourth quarter of fiscal 2022 with approximately 646 million in backlog. A significant portion of our reported backlog amount is derived from future TTK-related recurring revenue streams, which are associated with both our SAS and production success fees, and account for approximately 90% of the total backlog amount. It is important to note that our current backlog is materially reduced from the reported backlog amount during our second quarter earnings call. The sole driver of this reduction is the removal of forward-looking recurring SATs and production fee revenue amounts due to our issuance of the default notice to Bud and Mary's in their subsequently filed lawsuit. Total gross loss in the associated negative gross profit margin in the third quarter of 2022 was a negative 4.1 million or roughly 58.6% of total revenue compared to a gross loss of 380,000 or 2.4% of total revenue in the third quarter of 2021. The comparative change in year-over-year third quarter gross loss and gross margin primarily reflects the deferral of the previously discussed $5.3 million in third quarter 2022 design and build revenue, offset by the incremental gross profit and gross profit margin contributions from our extraction-related product sales. Extraction-related revenues achieved a gross profit margin of approximately 27% in the third quarter of 2022. The company was not able to defer the construction costs with the deferred design and build revenue during the third quarter of 2022, which significantly impacted the company's overall gross profit and gross margin performance during the third quarter. Moving on to operating expenses. Third quarter 2022 general and administrative expenses increased by 16.4 million or 213% to 24.1 million compared to 7.7 million in the third quarter of 2021. The comparative increase in G&A expenses in 2022 is largely attributable to a $15 million increase in bad debt reserves primarily associated with our decision to place a full reserve against all of the outstanding receivable balances under the Bud and Mary's TTK Solution Project. Approximately 1.1 million in severance-related charges as the company has begun to streamline operations in response to the current industry headwinds, and a comparative 500,000 increase in quarterly stock-based compensation as a result of equity awards issued to employees during the third quarter of 2022. Sales and marketing expenses totaled 2.2 million in the third quarter of 2022, compared to $890,000 in the third quarter of 2021. Consistent with prior quarters, the comparative increase in third quarter 2022 sales and marketing expenses is directly related to the company increasing the scale of its business while strategically focusing on investments in sales and marketing activities, such as headcount trade shows, marketing programs, et cetera, necessary to support our drive for top-line revenue growth. Research and development expenses in the third quarter of 2022 totaled 1.7 million compared to 827,000 in the third quarter of 2021. The increase in comparative quarterly research and development expense reflects the company's continued development efforts focused upon improving and upgrading our Agrify Insight stat software, as well as the hardware features and functionality of our vertical farming units. Comparative third quarter 2022 increases and R&D expenses are related to the current quarter edition of extraction division R&D teams, third-party consulting, payroll and related expenses, as well as material costs. The company, as of September 30, 2022, is currently monitoring two separate contingent earn-out consideration arrangements associated with the acquisitions of Pure Pressure and Lab Society. Each of the arrangements contains two consecutive 12-month earn-out periods, The potential additional consideration that can be earned under each of the two earnouts is capped at $1.5 million per year under the peer pressure earnout arrangement and $1.75 million per year under the lab society earnout arrangement. The company made initial estimates with respect to the probability of achievement of the additional consideration to be earned under each respective earnout period and recorded it as part of our initial purchase price accounting associated with each acquisition. Operating expenses in the third quarter of 2022 also includes a $602,000 reduction in operating expenses, which is primarily attributable to the change in our fear value estimates of contingent consideration associated with the currently active peer pressure earnout. During our periodic review of fear value estimates, we noted that peer pressure's actual revenue performance related to its first earnout period trails our initially projected revenue estimates. Accordingly, we revised our estimated probabilities of earn-out achievement, which resulted in a reduction in the original estimated earn-out achievement of approximately $602,000. This change in consideration, as required by GAAP, was recorded as a current period reduction to operating expenses. We will continue to evaluate on a routine periodic basis future performance against our initial assumptions and estimates on a quarterly basis. Any identified changes to our original assumptions that generate a change in our initial fair value estimates of probable earn-out achievement will result in either an increase or reduction to our future periodic operating expenses. Moving on to other income and expenses. The company is reporting total other expense of $14.7 million in the third quarter of 2022. This compares to other income of $30,000 in the year-ago quarters. There are several items during the year-over-year change in other income as we try to break them down into digestible sections. Starting with net interest expense, net interest expense totaled $4 million during the third quarter of 2022. Our third quarter interest expense is comprised of both normal interest expense associated with the outstanding principal balance of our existing debt facility, plus an incremental prepayment penalty of interest expense of $2.2 million, which was incurred in connection with the modification of our debt facility in the third quarter of 2022. Other income. The company is reporting $1.5 million of other income during the current quarter in connection with the finalization and true-up of previously estimated acquisition-related networking capital amounts. The finalization of the estimated amounts resulted in a favorable adjustment to the initial purchase price paid by the company at the close of our acquisitions. As we fully impaired our goodwill assets as of June 30, 2022, these adjustments cannot be recorded against the existing goodwill balance, which results in them being recorded as a favorable other income item in our third quarter statement of operations. We are reporting a loss on extinguishment of debt. As previously mentioned, in August 2022, the company entered into an agreement to restructure its March 2022 debt facility with its institutional lender. The company reviewed the terms of the modification and determined that the modification resulted in an extinguishment of the existing debt arrangement and not a modification. The company recognized a loss on debt extinguishment of approximately $17.9 million during the third quarter of 2022. This loss was comprised of a write-off of unamortized warrant costs, unamortized issuance costs, default penalty charges, and incremental charges associated with the fair value of the modified warrants. We are also reporting a change in the fair value of warrants. As part of the debt restructuring agreement, the company agreed to modify the strike price of the warrants issued under the original debt facility, as well as to issue new warrants under the new facility. The company, in its review of the accounting treatment to be applied to the new and existing warrants, determined that the warrants qualified for treatment as a liability instrument as opposed to being treated as an equity instrument. The company recognized a favorable charge in its third quarter 2022 statement of operations in connection with the periodic fair market value revaluation of the warrants, totaling $5.7 million. It is important to note that the company will continue to perform a review of the changes in the fair value of the warrants on a periodic basis, which will result in future gains and or losses in its statement of operations. A quick comment on income taxes. The company didn't recognize any income tax expense or benefit in the third quarter of 2022 or 2021. This is solely the result of the company having a full valuation allowance against the carrying value of its deferred tax attributes. We consolidate the results of operations of less than wholly owned entities into our consolidated results of operations. Agrify Valiant LLC, a joint venture limited liability company in which we are the 60% majority owner, and Valiant America LLC owns the remaining 40%. The net income or loss in each of the presented quarterly periods ended September 30th, 2022 and 2021 represents the portion of periodic income or loss attributable to the non-controlling parties. Finally, the net results of the previously discussed changes in revenue, gross margin, and operating expenses resulted in a reported net loss of $46.3 million, or $17.33 per diluted share, during the third quarter of 2022, compared to a loss of $9.8 million, or $4.68 per diluted share, in the year-ago quarter. It is also important to note that the company, with stockholder approval, completed a 1-for-10 reverse stock split on October 18, 2022. Accordingly, the company has retroactively adjusted all current period and historical equity and share-based information included in our third quarter 2022 financial statements and disclosures to reflect this 1 for 10 reverse stock split. Adjusted EBITDA amounted to a loss of $28.8 million during the third quarter of 2022 compared to an adjusted EBITDA loss of $5.6 million in the year-ago quarter. Additional information regarding our use of non-GAAP measures, including a reconciliation to the most comparable GAAP measures, can be found in the press release we issued earlier this morning, which is also available on the investor relations section of our website at www.agrify.com. Finally, a few quick comments on some other financial items. We ended the third quarter of 2022 with a combined amount of cash, restricted cash, and marketable securities of $12.5 million. compared to a balance of $56.6 million as of December 31, 2021. Subsequent to the end of the third quarter of 2022, the company began issuing shares of its common stock under a previously announced at-the-market equity program. As of November 7, 2022, the company has sold a total of 6,132,565 shares of common stock under the ATM program for aggregate gross proceeds of approximately $15.6 million and net proceeds after deducting commissions of approximately $15.1 million. As of November 7, 2022, the company had $34.4 million of remaining availability for future issuances of common stock under the ATM program. As of September 30, 2022, the company is in compliance with the financial debt covenants associated with its restructured $35 million senior secured promissory note. That concludes the prepared financial comments. And with that, I will now turn the call back to Raymond for final comments.
spk09: Thank you, Tim.
spk07: I would now like to turn to our guidance for the remainder of fiscal year 2022. Since we are deferring the $5.3 million of Buttonberry's revenue for the reasons stated above, we are reducing our guidance down to $65 to $70 million versus the original guidance of 70 to 75 million. In other words, if it wasn't for the 5.3 deferred revenue, we would have been on track to deliver our previously guided forecasts. I would now like to open up the call to questions. Operator, please go ahead.
spk02: Thank you. We will now be conducting a question and answer session. If you would like to ask a question, please press star then 1 on your telephone keypad. A confirmation tone will indicate your line is in the question queue. You may press star and then 2 if you would like to remove your question from the queue. For participants using speaker equipment, it may be necessary to pick up your handset before pressing the star keys. One moment please while we poll for questions. Our first question is from Aaron Gray of Alliance Global Partners. Please go ahead.
spk06: Hi, good morning. This is Remy Smith on for Aaron Gray. Thank you for the questions. You touched on this kind of a little bit in your opening remarks, but is there any kind of more market share or retail sales data in the markets where partners are selling products cultivated within BFUs and those legacy states? Just want to get a little bit more color on that for the data points to demonstrate the
spk09: flowing to retail sales. Thank you.
spk07: Yes, so our customers, you know, in Nevada, White Cloud continues to sell through their dispensaries. They had to do a restart because of some licensing issue, but they're basically coming back on track. And so far, the flowers that they have been able to sell through the retail have been deemed as very high quality, and they continue to produce, and the yield continues to go up. And we expect that once the restarts come to fruition, they will be able to, again, sell at a very high premium in the bottom market.
spk09: Great.
spk06: And then my second question regarding the extraction business. You have a strong line of sight in terms of the pipeline, particularly as we are seeing a number of operators pull back on CapEx. Are there any other factors to think about outside the macro that might be impacting the extraction business, such as competing products and pricing?
spk07: We still continue to see very strong pipeline as well as momentum behind our extraction business. As mentioned earlier, the pipeline for our extraction business stands at over $40-plus million, and we're seeing a very, very strong rebound in the fourth quarter in our extraction division. And as mentioned also, in Q3, unfortunately, because of the tight cash covenants and also some customer, what do you call it, delays on the completion of the facility construction, roughly about $3 million of business was kind of pushed into Q4, which we expect to ship this quarter. So, yeah, so we're continuing to see very strong momentum behind – positive momentum behind our extraction division, definitely a rebound from quarter three. And as I also mentioned earlier, we continue to innovate, you know, with new products. At the launch of the PX10, it's one, and we will be also introducing additional new products in the upcoming MJBiz as well.
spk09: Great. Thank you. Our next question is from Eric Delory of Craig Hellam.
spk02: Please go ahead.
spk04: Great. Thank you for taking my questions. I was wondering if you could comment a bit on the extraction businesses, the overall sort of demand that you're seeing for those products, and then if the sort of, you know, taking those extraction products and really implementing the you know, control and visibility into those and essentially creating, you know, a similar like TTK type offering for extraction. Just wondering if that is still, you know, on the sort of near-term strategy list here and just overall comments about the extraction business would be great. Thank you.
spk07: Yeah, Eric, we're definitely looking seeing a rebound of the momentum like I said for quarter four I think what's happening now is yes obviously due to the macro you know market condition you know in quarter three there were some hold back on the spending but I think we're seeing a reversal of that trend even starting from October timeframe. And like I said, I think this quarter we're seeing a very, very positive reversal of that trend. What is also actually very encouraging for us is that our parts sales and also e-commerce are recording probably some of the strongest numbers that we have seen. I think what's happening now is probably some people are just kind of instead of maybe making new purchases, we're trying to basically retrofit some of their existing products. And so we're seeing a very, very strong parts in e-commerce sales out of our extraction division. And we're also seeing adoption of our new technology. As I mentioned, we launched PX10, the latest technology innovation on the hydrocarbon side. And already we have three customers using this solution. And we're also seeing very, very strong interest towards some of the other new product innovations that we're introducing into the market. As to basically the consistency and quality issue that you mentioned, absolutely. That is something that we continue to work on. And in fact, the RDP program that we are rolling out as of today actually gives customers the option to basically buy an equivalent solution beyond just cultivation. So they could actually buy complementary extraction, total turnkey solution that, for example, if they purchase 56 VFUs, then we would basically do some calculation with them. And depending on the type of products that they want to produce, we would then design an extraction lab that provides them with a complete solution so that they could actually offer more products into the market. And I think that combination of cultivation and extraction are becoming extremely, extremely attractive. And in fact, a lot of the RDP programs, the customers are actually adopting or subscribing to this additional optional upgrade to take on both the extraction as well as the cultivation solutions. We are not yet ready to basically launch TTK around extraction yet. Most of the RDP programs that we're selling right now is still basically based on basically just upfront cash sales. We still need to do a bit of work to be able to turn the existing extraction equipment to be able to control remotely through cloud. And once that is completed, then we would be able to offer the TTK program because, as you know, very much similar to kind of the VFUs, we want to be able to remotely control as well as monitor the performance of the extraction equipment before we offer the TTK program. And that's something that we continue to work on.
spk09: Thank you. Our next question is from Anthony Venditti of Maxim Group.
spk02: Please go ahead.
spk08: Thanks. I just wanted to go over a couple of the numbers. Did you say the qualified pipeline has about $31.1 million in cultivation and $45.9 million in extraction? That's correct, $31.1 and $45.9. Okay. And usually, or sometimes you give a backlog number, which are the signed contracts. What was the backlog number at the end of the third quarter?
spk07: Kim, can you have the most accurate number? Kim, can you provide that, please?
spk05: Yeah, yeah, yeah. Anthony, we actually did. I gave that number as part of my script. So the backlog number, as reported in my script, was 646,000. as of the end of the third quarter. Obviously, the majority of that being SAS-related fees and production-based fees, and that amount of that backlog number, that represents about 90% of the total backlog number.
spk08: $646 million, yes.
spk05: Sorry, I apologize. Yeah, yeah. Okay. And typically, just remind us, Tim, that's
spk08: over a 10-year period, typically, how that gets recognized?
spk05: Yeah, the SAS and production fees are predominantly over a 10-year period based upon the initial CTK engagement. As we look at things like Raymond talked about, the RDP program, while those are a point-in-time equipment sale, they also do come with some limited period SAS and production fee revenue. So that would be on a shorter string or a shorter timeline. But the majority of that SAS and production is spread over 10 years.
spk08: Okay, and then with the Bud and Mary's lawsuit, can you talk about where that's currently at? And, you know, I know you probably don't have an exact timeline of how this is expected to roll out because these things could take sometimes years, but have you had any settlement talks with them? Maybe just give us an update on where you are with Bud and Mary's.
spk07: Anthony, as much as I would love to, I don't think we are allowed to basically get into the details while the legal is underway. But what I can tell you is that we are very, very confident that we will be able to recover 100% of you know, basically everything that we invested into this project. And we have both the resources as well as the legal means to go after this. And as I mentioned earlier also, that the project does come with both the corporate as well as personal guarantee from David Morgan, the founder and CEO of Bud and Mary's. And you know, the, the, well, unfortunately, while the, the, the pending lawsuit is still ongoing, I basically was advised that, you know, we're not allowed to discuss too much of it, but it is moving in the right direction. You know, and we have all the resources as well as the legal means to recover.
spk08: Okay. So, so, so David Morgan, the founder, so it's not just the, commercial assets, but his personal assets that were part of the agreement, and you have the right in the contract to recover lost revenue or revenue that is due under that contract through Bud and Mary's as well as his personal assets.
spk07: That is correct. So the corporate guarantees, we have both the corporate as well as personal guarantees. On the corporate side, they own the dispensary license. They have a home delivery license as well as two multiple cultivation licenses and product manufacturing license. And as I mentioned earlier, this is actually guaranteed by not only corporate, but David Morgan, the founder, CEO personally.
spk08: Okay. In terms of new business, in terms of building a pipeline, how has this lawsuit impacted future business? Is it taking a little bit longer to close new business as maybe customers are wondering what the issues are? Or have you seen a change at this point?
spk07: So Anthony, I think as we have kind of emphasized, given that kind of change in the market condition, we have decided that to not invest further into the TTK projects or future TTK projects at this moment. Obviously, the ones that we are committed to, every single one of them, we have the resources to basically bring them to fruition, right? And that's basically the three that I talked about earlier. We have resources dedicated for Bud and Mary's And also, you know, we have other TTK projects such as Goat Leaf that we have allocated VFU equipment towards. So all those projects, we are fully committed to basically bringing to fruition. Now, simultaneously, what is really picking up steam is the rapid deployment program, right? You know, in the past, You know, TTK, as you know, is basically a large long-term investment that requires substantial capital outlay from the company up front. And given kind of the market condition today, I don't believe that the market no longer has that sort of, you know, appetite. The RTP program is really what is selling out there. You know, people can get started with, $2 to $3 million investment. And in fact, if they could get started with even less capital, they could just basically purchase eight of our VFUs and then they would have sufficient biomass to maybe support one dispensary. So it really kind of gives the customers the flexibility to be able to scale over time and also not having to wait 12, 15 months, large capital outlay to get projects going. So this rapid deployment program is really what's picking up steam. And unlike the TTK program where it requires AgriFi to put in all the capital upfront and invest at our risk, we are basically selling all the hardware with margin, plus there's also recurring stats and production fees attached to it. And I think this new model is really what's resonating And even with very little marketing, you know, we actually, in fact, initially did not plan to really kind of sell this or market this until MJBiz. But as I mentioned earlier, we're already seeing tremendous traction. And with MJBiz coming up, I think, you know, it's just going to pick up even more steam. So it's a pivot of our business model, which I think is the right thing to do given the current market condition. And people see that as completely different from the old TTK model that, you know, basically was what we kind of focused on last year and, you know, first half of this year.
spk08: Okay. And then last question is Tim mentioned about some severance and cost reductions. Cash flow using the corridor from operating activities was $8.5 million. With the cost reductions that are in place now, what is the new expected cash flow use, Tim? Have you modeled what that would be or what you expect it to be, a range for the fourth quarter?
spk05: Yeah, that's a good question, but I don't give cash flow guidance, right? We're not going to guide cash flow. You know, we're... Happy and pleased that cash flow from Ops was only $8.5 million relative to what the historical track record in Q1 and Q2 were. But I will tell you, you have to think about the question you asked as it relates to or in conjunction with the restructured debt agreement. The terms of that debt agreement state that the company is limited from a net cash spend point of view of $4 million in net cash flow spend per month and $8 million per quarter in aggregates. So that is sort of the guide rails that we have to operate on or under as we move forward through Q4 into 2023. So given that, I just think relationally to where we are right now and what the parameters are of that restructured debt agreement, you would expect that cash flow from ops number to be either consistent where it was in Q3 or lower as we move through Q4.
spk09: Okay, thanks. I'll hop back into Q. Appreciate it. Our next question is from Scott Fortune of Roth Capital Partners.
spk02: Please go ahead.
spk03: Hey, good morning. This is Nick on for Scott. Just looking for some color on your recent harvest metrics. With the RDP set to roll out here, just wondering if you've seen any improvements you want to call out on the yield or the potency side, and just kind of how you're looking at further improving the VFU product moving forward here in this environment. Thank you.
spk07: Yeah, so... And, Nick, so basically the RDP program, as I mentioned, we are just now taking orders. So they have actually not been shipped. We are expecting to ship some of the existing orders in the coming quarter. So we do not yet have the operating metrics for those RDP programs just yet. But they're using our traditional 3.6 VFUs. So I would say that you can expect to pretty much get the same sort of results from the 3.6. As I've also mentioned earlier, the new 3.7 BFU development is now complete, and we can actually begin to ship the 3.7 units in first quarter of next year. And we believe that you could expect to have even better yield and results from the new 3.7 VFU, which we will also be featuring and showcasing at the upcoming MJBiz.
spk03: Okay. Thank you for that, Collar. And then just looking for an update on the status of your supply chain and whether or not you've seen those headwinds kind of begin to abate here. Just if you could unpack the changes you've seen within your supply chain in this environment, that would be helpful, too. Thank you.
spk07: Yeah, I think on the cultivation side, we have sufficient inventory to basically fulfill our most immediate customer orders. So from that perspective, I think supply chain is not going to necessarily affect our ability to ship these units. I think construction delays are still maybe happening, but we're seeing that pressure subside or basically reducing. We do expect that on the cultivation front, supply chain is probably not going to be too big of an issue. On the extraction front, we do still work with our vendor suppliers You know, obviously in Q3, probably not so much of the supply chain issue, but, you know, obviously because of the cash spent covenant, we weren't able to fulfill some of that orders. But I think that is something that we still have to probably fight through in quarter four. But I think it seems like, you know, both internally and externally, supply chain pressure is probably getting higher getting resolved, but it's not completely, but we definitely see some improvements around that.
spk09: Great. That's it for me. I appreciate the call.
spk02: We have reached the end of the question and answer session. I would now like to turn the call back over to Raymond Chang for any closing comments. Please go ahead, sir.
spk07: Thank you, everyone, for joining the call today. and look forward to speaking in our next quarter call. Again, appreciate and look forward to giving everybody an update as we continue to focus on our execution and deliver results.
spk09: Thank you.
spk02: That concludes today's conference. Thank you for joining us. You may now disconnect your lines.
Disclaimer